Disease & disorder

leukemia

MONDO:0005059

A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.

Clinical trials109
Recruiting11
Drug concepts studied20
Synonyms9

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Leukemia

Leukemia (also spelled leukaemia; pronounced loo-KEE-mee-ə) is a group of blood cancers that usually begin in the bone marrow and produce high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. Signs and symptoms may include bleeding and bruising, bone pain, fatigue, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy. The exact cause of leukemia is still under research. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, petrochemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—and a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues. Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, with supportive and palliative care provided as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the devel...

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and EffectsNCT06800586 · 2025-09-15
RECRUITING
Cardiovascular Risk in Children With Chronic Conditions StudyNCT07086989 · 2025-04-01
RECRUITING
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialNCT06580002 · 2024-12-02
RECRUITING
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesNCT07270263 · 2024-11-22
RECRUITING
Breath Analysis for the Detection of Invasive Fungal InfectionsNCT06537726 · 2024-08-19
RECRUITING
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)NCT05403177 · 2022-06-23
RECRUITING
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseNCT05366881 · 2022-05-03
RECRUITING
Early Ageing During Therapy in AYA Cancer PatientsNCT05062707 · 2022-02-10
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNCT03452774 · 2018-01-01
RECRUITING
Liquid Biopsy Evaluation and Repository Development at Princess MargaretNCT03702309 · 2017-08-03
RECRUITING
Integrated Cancer Repository for Cancer ResearchNCT02012699 · 2013-11-01
RECRUITING
Natural History Study of Early Life Exposures in Agriculture (ELEA)NCT07328516 · 2026-10-12
ENROLLING_BY_INVITATION
Weight Gain in Pediatric Leukemia SurvivorsNCT07374315 · 2026-08-31
NOT_YET_RECRUITING
YASU Research Registry: For Young Adults With CancerNCT06275854 · 2025-02-03
TERMINATED
Integrated Actionable Aging Assessment for Cancer Patients PilotNCT05871008 · 2024-03-01
ACTIVE_NOT_RECRUITING
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)NCT05692713 · 2023-07-01
UNKNOWN
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised IndividualsNCT05655546 · 2022-12-22
TERMINATED
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA StudyNCT04593277 · 2022-10-23
COMPLETED
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsNCT05131815 · 2022-07-25
COMPLETED
Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or LeukemiaNCT04541212 · 2021-12-02
ACTIVE_NOT_RECRUITING
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk PopulationsNCT05393999 · 2021-11-29
WITHDRAWN
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNCT05635266 · 2021-10-26
UNKNOWN
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood CancerNCT04977024 · 2021-09-27
ACTIVE_NOT_RECRUITING
IIT2020-20-SHIRAZIP-WALK: Nature WalksNCT04896580 · 2021-06-21
COMPLETED
Observational Study of People Living With HIV Treated With CD19-directed CAR T CellNCT05784415 · 2021-05-22
COMPLETED
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNCT04604158 · 2020-12-02
COMPLETED
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 StudyNCT04372524 · 2020-11-15
UNKNOWN
Tempus Priority Study: A Pan-tumor Observational StudyNCT05179824 · 2020-10-19
ACTIVE_NOT_RECRUITING
Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte LeukemiaNCT03759184 · 2019-07-11
TERMINATED
HeartPhone Cancer Survivors Trial 2019NCT03953326 · 2019-04-23
TERMINATED
PROactive Evaluation of Function to Avoid CardioToxicityNCT03862131 · 2019-03-13
TERMINATED
Total Body Irradiation Treatments for Patients Treated at European Institute of OncologyNCT06335277 · 2018-02-22
UNKNOWN
TKI Discontinuation in CML Patients of ChinaNCT03251352 · 2017-03-01
UNKNOWN
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical TrialsNCT02948413 · 2016-11-10
COMPLETED
Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via ChemotherapyNCT02796365 · 2016-06-01
COMPLETED
Post-transfusion Platelet CountNCT02601131 · 2016-02-01
COMPLETED
Aberrant Myeloid Lineage Differentiation in HIV/AIDS PatientsNCT05808803 · 2016-01-01
COMPLETED
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs TherapyNCT02638467 · 2015-11-01
COMPLETED
Survivorship Care in Reducing Symptoms in Young Adult Cancer SurvivorsNCT02192333 · 2015-08-03
COMPLETED
Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)NCT02583815 · 2015-08-01
COMPLETED

Leading sponsors

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.